vs
Side-by-side financial comparison of MEDIFAST INC (MED) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
COMSCORE, INC. is the larger business by last-quarter revenue ($93.5M vs $75.1M, roughly 1.2× MEDIFAST INC). On growth, COMSCORE, INC. posted the faster year-over-year revenue change (-1.5% vs -36.9%). COMSCORE, INC. produced more free cash flow last quarter ($2.9M vs $-6.6M). Over the past eight quarters, COMSCORE, INC.'s revenue compounded faster (3.8% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
MED vs SCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $93.5M |
| Net Profit | — | $3.0M |
| Gross Margin | 69.4% | 41.0% |
| Operating Margin | -10.4% | 7.0% |
| Net Margin | — | 3.2% |
| Revenue YoY | -36.9% | -1.5% |
| Net Profit YoY | — | -3.7% |
| EPS (diluted) | $-1.64 | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $93.5M | ||
| Q3 25 | $89.4M | $88.9M | ||
| Q2 25 | $105.6M | $89.4M | ||
| Q1 25 | $115.7M | $85.7M | ||
| Q4 24 | $119.0M | $94.9M | ||
| Q3 24 | $140.2M | $88.5M | ||
| Q2 24 | $168.6M | $85.8M | ||
| Q1 24 | $174.7M | $86.8M |
| Q4 25 | — | $3.0M | ||
| Q3 25 | $-2.3M | $453.0K | ||
| Q2 25 | $2.5M | $-9.5M | ||
| Q1 25 | $-772.0K | $-4.0M | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | $1.1M | $-60.6M | ||
| Q2 24 | $-8.2M | $-1.7M | ||
| Q1 24 | $8.3M | $-1.1M |
| Q4 25 | 69.4% | 41.0% | ||
| Q3 25 | 69.5% | 40.6% | ||
| Q2 25 | 72.6% | 40.6% | ||
| Q1 25 | 72.8% | 39.6% | ||
| Q4 24 | 74.1% | 42.4% | ||
| Q3 24 | 75.4% | 41.2% | ||
| Q2 24 | 73.2% | 39.5% | ||
| Q1 24 | 72.8% | 42.3% |
| Q4 25 | -10.4% | 7.0% | ||
| Q3 25 | -4.6% | 1.9% | ||
| Q2 25 | -1.0% | -1.9% | ||
| Q1 25 | -1.1% | -2.4% | ||
| Q4 24 | 0.6% | 4.1% | ||
| Q3 24 | 1.5% | -67.4% | ||
| Q2 24 | -4.7% | -2.2% | ||
| Q1 24 | 4.5% | -2.2% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | -2.5% | 0.5% | ||
| Q2 25 | 2.3% | -10.6% | ||
| Q1 25 | -0.7% | -4.7% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | 0.8% | -68.5% | ||
| Q2 24 | -4.8% | -2.0% | ||
| Q1 24 | 4.8% | -1.2% |
| Q4 25 | $-1.64 | $9.50 | ||
| Q3 25 | $-0.21 | $-0.86 | ||
| Q2 25 | $0.22 | $-2.73 | ||
| Q1 25 | $-0.07 | $-1.66 | ||
| Q4 24 | $0.08 | $-0.47 | ||
| Q3 24 | $0.10 | $-12.79 | ||
| Q2 24 | $-0.75 | $-1.19 | ||
| Q1 24 | $0.76 | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $23.6M |
| Total DebtLower is stronger | — | $41.5M |
| Stockholders' EquityBook value | $198.9M | $111.4M |
| Total Assets | $248.0M | $407.7M |
| Debt / EquityLower = less leverage | — | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $23.6M | ||
| Q3 25 | $173.5M | $26.7M | ||
| Q2 25 | $162.7M | $26.0M | ||
| Q1 25 | $164.6M | $31.0M | ||
| Q4 24 | $162.3M | $29.9M | ||
| Q3 24 | $170.0M | $20.0M | ||
| Q2 24 | $163.5M | $14.7M | ||
| Q1 24 | $156.4M | $18.7M |
| Q4 25 | — | $41.5M | ||
| Q3 25 | — | $41.4M | ||
| Q2 25 | — | $41.3M | ||
| Q1 25 | — | $41.3M | ||
| Q4 24 | — | $41.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $198.9M | $111.4M | ||
| Q3 25 | $214.7M | $-26.3M | ||
| Q2 25 | $216.0M | $-21.7M | ||
| Q1 25 | $211.0M | $-13.5M | ||
| Q4 24 | $210.1M | $-8.3M | ||
| Q3 24 | $207.3M | $-2.7M | ||
| Q2 24 | $205.3M | $45.8M | ||
| Q1 24 | $211.0M | $51.4M |
| Q4 25 | $248.0M | $407.7M | ||
| Q3 25 | $268.2M | $406.9M | ||
| Q2 25 | $269.3M | $415.9M | ||
| Q1 25 | $280.0M | $421.5M | ||
| Q4 24 | $284.2M | $430.2M | ||
| Q3 24 | $291.2M | $412.5M | ||
| Q2 24 | $293.5M | $474.1M | ||
| Q1 24 | $302.8M | $477.7M |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $3.2M |
| Free Cash FlowOCF − Capex | $-6.6M | $2.9M |
| FCF MarginFCF / Revenue | -8.8% | 3.1% |
| Capex IntensityCapex / Revenue | 1.8% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $3.2M | ||
| Q3 25 | $12.1M | $9.5M | ||
| Q2 25 | $-3.4M | $932.0K | ||
| Q1 25 | $3.4M | $9.1M | ||
| Q4 24 | $-4.9M | $-10.0M | ||
| Q3 24 | $9.1M | $12.5M | ||
| Q2 24 | $13.1M | $8.7M | ||
| Q1 24 | $7.3M | $6.9M |
| Q4 25 | $-6.6M | $2.9M | ||
| Q3 25 | $10.8M | $9.4M | ||
| Q2 25 | $-4.8M | $787.0K | ||
| Q1 25 | $1.9M | $8.7M | ||
| Q4 24 | $-7.2M | $-10.3M | ||
| Q3 24 | $7.7M | $12.4M | ||
| Q2 24 | $11.1M | $8.5M | ||
| Q1 24 | $5.4M | $6.6M |
| Q4 25 | -8.8% | 3.1% | ||
| Q3 25 | 12.0% | 10.5% | ||
| Q2 25 | -4.5% | 0.9% | ||
| Q1 25 | 1.6% | 10.1% | ||
| Q4 24 | -6.1% | -10.8% | ||
| Q3 24 | 5.5% | 14.0% | ||
| Q2 24 | 6.6% | 10.0% | ||
| Q1 24 | 3.1% | 7.6% |
| Q4 25 | 1.8% | 0.3% | ||
| Q3 25 | 1.5% | 0.1% | ||
| Q2 25 | 1.3% | 0.2% | ||
| Q1 25 | 1.3% | 0.4% | ||
| Q4 24 | 1.9% | 0.2% | ||
| Q3 24 | 1.0% | 0.1% | ||
| Q2 24 | 1.1% | 0.2% | ||
| Q1 24 | 1.1% | 0.3% |
| Q4 25 | — | 1.07× | ||
| Q3 25 | — | 20.96× | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.19× | ||
| Q3 24 | 8.04× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
